About Us - Overview

AvivoClin’s custom, state-of-the-art clinical pharmacology research unit brings together an impressive blend of experience and services. AvivoClin’s management has performed a broad spectrum of clinical studies across virtually every therapeutic area.

Working with local hospitals and organizations, we offer customized solutions for our clients’ early phase clinical research needs. AvivoClin’s clinic is strategically located to meet the appropriate demographic profile for recruiting healthy volunteers and specialty patient populations for early phase clinical trials. Our experienced staff ensures that studies are conducted in compliance with FDA/ICH guidelines and regulations.

Additionally, our Phase I Express™ process is designed to help clients successfully manage the transition from preclinical to Phase I studies, enabling them to make effective and fast decisions about safety and efficacy of their compounds. Our goal is to streamline the development process, saving our clients time and money.

The Azopharma Product Development Group

The Azopharma Product Development Group provides comprehensive development services for the pharmaceutical, biotech and medical device industries. Our affiliate companies, all wholly owned by Azopharma, provide services from preclinical to post commercialization.

These companies include:

Integrated product development and CTM manufacturing for all dosage forms.		Preclinical services in support of early product development.
Proprietary drug delivery platforms to solve difficult molecular challenges.		Synthetic chemistry services from discovery to clinical API supplies including large scale API synthesis.
Analytical chemistry and inhalation services from development to quality control testing.		Human clinical pharmacology services for Phase I/II/III clinical trials.